- List
- By Topic
- On Map
- Search Details

14627786 [PUBMED-IDS]
Need help? See RSS Feeds
Choose a feed type:

14627786 [PUBMED-IDS] (2 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT02701205 | Unknown † | Safety and Efficacy Study of Etanercept (Qiangke®) to Treat Moderate to Severe Plaque Psoriasis |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
216 | All | 18 Years to 65 Years (Adult) | NCT02701205 | QRSTPP | January 2015 | January 2017 | December 2017 | March 8, 2016 | March 8, 2016 |
|
||
2 | NCT00940862 | Completed | Effect of Adalimumab on Vascular Inflammation in Patients With Moderate to Severe Plaque Psoriasis |
|
|
Interventional | Phase 4 |
|
Other / Industry |
|
|
30 | All | 18 Years to 80 Years (Adult, Senior) | NCT00940862 | Inno-6009 | July 2009 | June 2011 | August 2011 | July 16, 2009 | October 28, 2011 |
|
† Study has passed its completion date and status has not been verified in more than two years.